Salisbury
United Kingdom
20
2025-03-06
The entities that hold a legal rights for patent applications filed by inventor Evans David Michael:
David Michael Evans from Salisbury, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors
#2 | 2022-11-17ENZYME INHIBITORS
#3 | 2022-09-22ENZYME INHIBITORS
#4 | 2022-09-22ENZYME INHIBITORS
#5 | 2022-09-15N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors
#6 | 2022-09-15ENZYME INHIBITORS
#7 | 2020-11-19N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
#8 | 2020-06-25N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
#9 | 2019-10-31N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
#10 | 2019-10-03N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
#11 | 2019-05-23Inhibitors of plasma kallikrein
#12 | 2018-11-08N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
#13 | 2017-10-26N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
#14 | 2017-09-07Benzylamine derivatives
#15 | 2016-06-30Bicyclic inhibitors
#16 | 2016-06-16Inhibitors of plasma kallikrein
#17 | 2016-04-21Heterocyclic derivates
#18 | 2016-02-11Benzylamine derivatives
#19 | 2015-08-13Benzylamine derivatives as inhibitors of plasma kallikrein
#20 | 2014-07-31Benzylamine derivatives as inhibitors of plasma kallikrein
855225 ⎘